PharmaLifeScience News

...

Swiss drugmaker Roche to invest $50bn in US in effort to dodge Trump tariffs

Company says it will create 12,000 jobs in manufacturing and R&D over next five yearsBusiness live – latest updatesThe Swiss drugmaker Roche has said it will put $50bn (37bn) into manufacturing in the US over the next five years, joining the queue of companies unveiling investments to try to head off potentially punitive Donald Trump tariffs.Roche said on Tuesday the investment would create more than 12,000 jobs, including 6,500 in construction and 1,000 at new and expanded existing facilities in the US, including factories and distribution centres in Kentucky, New Jersey and California. Continue reading...
READ MORE
...

Axtria unveils transformational agentic AI platform for life sciences

Axtria Inc., an AI-first data analytics innovator and global provider of cloud software to the life sciences industry, today announced the launch of Axtria InsightsMAx.ai. 

READ MORE
...

Regeneron partners with Fujifilm to broaden manufacturing capacity

Regeneron Pharmaceuticals has entered a new manufacturing and supply agreement with Fujifilm Diosynth Biotechnologies.
READ MORE